JDRF and CIHR Announce New Grants to Accelerate Stem-Cell Based Therapies for T1D

To mark November’s National Diabetes Awareness Month, JDRF announced a new investment for a total of $6 million to support two Canadian research teams as part of the JDRF-CIHR Partnership to Defeat Diabetes to help accelerate development of stem cell-based therapies for type 1 diabetes (T1D).